Gómez CLM, Quintero MY, Pereira VE

Language: Spanish
References: 13
Page: 110-116
PDF size: 645.24 Kb.

ABSTRACT

Sars-Cov-2, is a virus belonging to the coronaviridae family, responsible for the pandemic that has been plaguing the world since December 2019, which produces the infectious disease called COVID-19. This disease is expressed in more than half of the cases in a mild and even asymptomatic way, however, in a non-negligible number of patients it manifests itself in its most severe form, with multiple complications, and can even cause death. Along with respiratory complications, cardiovascular complications are present mainly in those patients who require admission to intensive care units, which make medical management difficult, as well as entail a worse prognosis. The case of a 70-years-old patient with a history of apparent health, who was admitted with respiratory symptoms and who, after performing the polymerase chain reaction technique with reverse transcriptase in real time, was positive for the Sars-Cov virus. -2, it was decided to transfer him to the Playa Girón Heroes Specialized Ambulatory Center, where he was hospitalized in the Intensive Care Unit for 6 days and died mainly as a result of cardiovascular complications is presented. The aim of this research is to present the case of a patient who suffered from respiratory symptoms as an initial presentation of the infection, for which a real-time polymerase chain reaction was performed, which was positive for SARS-CoV- 2.

REFERENCES

1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.

2. Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health. The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91(10):264-66.

3. Dabanch J. Emergencia de SARS-CoV-2. Aspectos básicos sobre su origen, epidemiología, estructura y patogenia para clínicos. Rev Med Clin Condes[Internet]. 2021[citado 10 Dic 2021];32(1):[aprox. 5p.]. Disponible en: https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-pdf-S0716864020300924.

4. Rozado J, Ayesta A, Morís C, Avanzas P. Fisiopatología de la enfermedad cardiovascular en pacientes con COVID-19. Isquemia, trombosis y disfunción cardiaca. Rev Esp Cardiol[Internet]. 2020[citado 11 Abr 2021];20(E):[aprox. 6p.]. Disponible en: https://www.revespcardiol.org.

5. Moreno FL, Moreno FL, Oroz R. Repercusión cardiovascular de la infección por el nuevo coronavirus SARS-CoV-2 (COVID-19). Corsalud[Internet]. 2020[citado 15 Ene 2021];12(1):[aprox. 15p.]. Disponible en: Disponible en: https://www.revcorsalud.sld.cu/index.php/cors/article/view/588 .

6. Figueroa JF, Salas DA, Cabrera JS, Alvarado CC, Buitrago AF. COVID-19 y enfermedad cardiovascular. Rev Colomb Cardiol[Internet]. 2020[citado 11 Abr 2021];27(3):[aprox. 8p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164891/.

7. Ministerio de Salud Pública. Protocolo de Actuación Nacional Para la COVID-19. Versión 1.6[Internet]. La Habana:MINSAP;2021[citado 2 Ene 2022]. Disponible en: Disponible en: https://instituciones.sld.cu/pdvedado/files/2021/02/PROTOCOLO-V.6-FEB.pdf .

8. Wang D, Hu B, Hu C, Zhu F, Xing Liu, Jing Zhang, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.

9. López D, López J, Antúnez PJ, Cacho C, González T, González JR. Asociación entre el daño miocárdico y el pronóstico de pacientes hospitalizados por COVID-19, con y sin cardiopatía. Registro CARDIOVID. Rev Esp Cardiol[Internet]. 2021[citado 19 Ene 2022]; 74(1):[aprox. 10p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494313/.

10. Gutiérrez A, Cruz M, Mengana A, Castañeda O, Martínez F, Falcón R. Arritmias cardíacas en pacientes con la COVID-19. Escenarios y tratamiento. Rev Cubana Cardiol Cir Cardiovas[Internet]. 2020[citado 25 Abr 2021];26(3):[aprox. 10p.]. Disponible en: https://www.revcardiologia.sld.cu.

11. Uribarri A, Núñez IJ, Aparisi A, Arroyo R, Maroun C, Romero R, et al. Fibrilación auricular en pacientes con COVID-19. Utilidad de la puntuación CHA2DS2-VASc: un análisis del registro internacional HOPE COVID-19. Rev Esp Cardiol[Internet]. 2021[citado 23 Dic 2021];74(7):[aprox. 12p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923850/.

12. Rodríguez M, Minguito C, Echarte JC, Del Castillo S, Valdivia J, Fernández F. Hallazgos ecocardiográficos en pacientes críticos por COVID-19. Rev Esp Cardiol[Internet]. 2020[citado 29 Abr 2021];73(10):[aprox. 4p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328579/.

13. Cordero A, Escribano D, Bertomeu V. Complicaciones cardiovasculares y pronóstico en pacientes con COVID-19. Rev Esp Cardiol Suppl[Internet]. 2020[citado 23 Oct 2021];20(E):[aprox. 4p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668213/.